比亞迪(01211.HK):純電動大巴和出租車已遍佈全球逾400個城市
據內媒報道,比亞迪(01211.HK)(002594.SZ)公佈,近期接受機構投資者的特定對象調研時透露,在商用車發展方面,比亞迪純電動大巴和出租車的足跡已遍佈全球逾70個國家和地區,逾400個城市。
乘用車出海業務進一步提速。截至目前,比亞迪新能源乘用車已進入日本、德國、澳洲及巴西等53個國家和地區。比亞迪首款全球車型BYD ATTO 3(元PLUS)在國際市場上獲得銷量和市場口碑「雙豐收」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.